Erythromycin inhibits tumor necrosis factor alpha and interleukin 6 production induced by heat-killed Streptococcus pneumoniae in whole blood

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 7, 1998, Pages 1605-1609

  Schultz, Marc J ^a,b   Speelman, Peter ^a   Zaat, Sebastian ^a   Van Deventer, Sander J H ^a   Van Der Poll, Tom ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROMYCIN; INTERLEUKIN 6; PENICILLIN G; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BACTERIAL PNEUMONIA; DRUG EFFECT; HOST RESISTANCE; HUMAN; IMMUNOREGULATION; LOBAR PNEUMONIA; NORMAL HUMAN; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE;

EID: 0031863215     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.7.1605     Document Type: Article

References (36)

1. Anderson, R. 1989. Erythromycin and roxithromycin potentiate human neutrophil locomotion in vitro by inhibition of leukoattractant-activated super-oxide generation and autooxidation. J. Infect. Dis. 159:966-973.
2. Bailly, S., J.-J. Pocidalo, M. Fay, and M.-A. Gougerot-Pocidalo. 1991. Differential modulation of cytokine production by macrolides: interleukin-6 production is increased by spiramycin and erythromycin. Antimicrob. Agents Chemother. 35:2016-2019.
3. Bailly, S., B. Ferrua, M. Fay, and M. A. Gougerot-Pocidalo. 1990. Differential regulation of IL-6, IL-1α, IL-1β and TNF-α production in LPS-stimulated monocytes: role of cyclic AMP. Cytokine 2:205-210.
4. Bohte, R., R. van Furth, and P. J. van den Broek. 1995. Aetiology of community-acquired pneumonia: a prospective study among adults requiring admission to hospital. Thorax 50:543-547.
5. Boutten, A., M. S. Dehoux, N. Sela, J. Ostinelli, P. Venembre, B. Crestani, M. C. Dombret, G. Durand, and M. Aubier. 1996. Compartmentalized IL-8 and elastase release within the human lung in unilateral pneumonia. Am. J. Respir. Crit. Care Med. 153:336-342.
6. Cassatella, M. A. 1995. The production of cytokines by polymorphonuclear neutrophils. Immunol. Today 16:21-23.
7. DeForge, L. E., J. S. Kenney, M. L. Jones, J. S. Warren, and D. G. Remick. 1992. Biphasic production of IL-8 in lipopolysaccharide (LPS)-stimulated human whole blood. Separation of LPS- and cytokine-stimulated components using anti-tumor necrosis factor and anti-IL-1 antibodies. J. Immunol. 148:2133-2141.
8. Dehoux, M. S., A. Boutten, J. Ostinelli, N. Seta, M. C. Dombret, B. Crestani, M. Deschenes, J. L. Trouillet, and M. Aubier. 1994. Compartmentalized cytokine production within the human lung in unilateral pneumonia. Am. J. Respir. Crit. Care Med. 150:710-716.
9. Friedland, I. R., and G. H. McCracken. 1994. Management of infections caused by antibiotic-resistant Streptococcus pneumoniae. N. Engl. J. Med. 331:377-382.
10. Fujii, T., J.-I. Kadota, T. Morikawa, Y. Matsubara, K. Kawakami, K. Iida, R. Shirai, H. Taniguchi, M. Kaseda, S. Kawamoto, and S. Kohno. 1996. Inhibitory effect of erythromycin on interleukin 8 production by 1α,25-dihydroxyvitamin D3-stimulated THP-1 cells. Antimicrob. Agents Chemother. 40:1548-1551.
11. Greenberger, M. J., R. M. Strieter, S. L. Kunkel, J. M. Danforth, R. E. Goodman, and T. J. Standiford. 1995. Neutralization of IL-10 increases survival in a murine model of Klebsiella pneumonia. J. Immunol. 155:722-729.
12. Greenberger, M. J., S. L. Kunkel, R. M. Strieter, N. W. Lukacs, J. Bramson, J. Gauldie, F. L. Graham, M. Hitt, J. M. Danforth, and T. J. Standiford. 1996. IL-12 gene therapy protects mice in lethal Klebsiella pneumonia. J. Immunol. 157:3006-3012.
13. Iiono, Y., M. Toriyama, K. Kudo, Y. Natori, and A. Yuo. 1992. Erythromycin inhibition of lipopolysaccharide stimulated tumor necrosis factor alpha production by human monocytes in vivo. Ann. Otol. Rhinol. Laryngol. 101:16-20.
14. Keicho, N., S. Sawada, and K. Kitamura. 1991. Effects of an immunosuppressant, FK506, on interleukin alpha production by human macrophages and a macrophage-like cell line. Cell. Immunol. 132:285-294.
15. Khair, O. A., J. L. Devalia, and M. M. Abdelaziz. 1995. Effect of erythromycin on Haemuphilus influenzae endotoxin induced release of IL-6, IL-8 and sICAM-1 by cultured human bronchial epithelial cells. Eur. Respir. J. 8: 1451-1457.
16. Klugman, K. P. 1990. Pneumococcal resistance to antibiotics. Clin. Microbiol. Rev. 3:171-196.
17. Kusunoki, T., E. Hailman, T. S. C. Juan, H. S. Lichenstein, and S. D. Wright. 1995. Molecules from Staphylococcus aureus that bind CD14 and stimulate innate immune responses. J. Exp. Med. 182:1673-1682.
18. Lambert, H. P., and F. W. O'Grady. 1992. Macrolides, p. 168-179. In H. P. Lambert and F. W. O'Grady (ed.), Antibiotic and chemotherapy, 6th ed. Churchill Livingstone, London, United Kingdom.
19. Möller, A., F. Emling, D. Blohm, E. Schlick, and K. Schollmeier. 1990. Monoclonal antibodies to human tumor necrosis factor α: in vitro and in vivo application. Cytokine 2:162-169.
20. Morikawa, K., H. Watabe, M. Araake, and S. Morikawa. 1996. Modulatory effect of antibiotics on cytokine production by human monocytes in vitro. Antimicrob. Agents Chemother. 40:1366-1370.
21. Mossmann, T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65:55-63.
22. Oishi, K., F. Sonoda, S. Kobayashi, A. Iwagaki, T. Nagatake, K. Matsushima, and K. Matsumoto. 1994. Role of interleukin-8 (IL-8) and an inhibitory effect of erythromycin on IL-8 release in the airways of patients with chronic airway diseases. Infect. Immun. 62:4145-4152.
23. Ortqvist, A., J. Hedlund, and L. Grillner. 1990. Aetiology, outcome and prospective factors in community acquired pneumonia requiring hospitalization. Eur. Respir. J. 3:1105-1113.
24. Philips, H. J. 1973. Dye exclusion tests for cell viability, p. 406-408. In P. P. Kruse, Jr., and M. K. Patterson (ed.), Tissue culture methods and applications. Academic Press, New York, N.Y.
25. Research Committee of the British Thoracic Society and the Public Health Laboratory Service. 1987. Community acquired pneumonia in adults in British hospitals in 1982-1983: a survey of aetiology, mortality, prognostic factors and outcome. Q. J. Med. 62:195-220.
26. Sherris, J. C., and J. J. Plorde. 1990. Antimicrobics and chemotherapy of bacterial and viral infections, p. 213-214. In J. C. Sherris (ed.), Medical microbiology. An introduction to infectious diseases. 2nd ed. Elsevier Science Publishing Co., Inc., New York, N.Y.
27. Suffredini, A. F., D. Reda, S. M. Banks, M. Tropea, J. M. Agosti, and R. Miller. 1995. Effects of recombinant dimeric TNF receptor on human inflammatory responses following intravenous endotoxin administration. J. Immunol. 155:5038-5045.
28. Takeyama, K., Y. Tamaoki, A. Chiotani, E. Tagaya, and K. Konno. 1993. Effect of macrolide antibiotics on ciliary motility in rabbit airway epithelium in vitro. J. Pharm. Pharmacol. 45:756-758.
29. Takizawa, H., M. Desaki, and E. Ohtoshi. 1995. Erythromycin suppresses interleukin 6 expression by human bronchial epithelial cells: a potential mechanism of its anti-inflammatory action. Biochem. Biophys. Res. Commun. 210:781-786.
30. Van der Poll, T., S. M. Coyle, K. Barbosa, C. C. Braxton, and S. F. Lowry. 1996. Epinephrine inhibits tumor necrosis factor α and potentiates interleukin 10 release during human endotoxemia. J. Clin. Invest. 97:713-719.
31. van der Poll, T., and S. F. Lowry. 1997. Lipopolysaccharide-induced interleukin 8 production by human whole blood is enhanced by epinephrine and inhibited by hydrocortisone. Infect. Immun. 65:2378-2381.
32. Van der Poll, T., and S. F. Lowry. 1997. Epinephrine inhibits endotoxin-induced interleukin-1β production: roles of tumor necrosis factor-α and interleukin 10. Am. J. Physiol. 273:R1885-R1890.
33. Van der Poll, T., A. Marchant, C. V. Keogh, M. Goldman, and S. F. Lowry. 1996. Interleukin 10 impairs host defense in murine pneumococcal pneumonia. J. Infect. Dis. 174:994-1000.
34. Van der Poll, T., C. V. Keogh, W. A. Buurman, and S. F. Lowry. 1997. Passive immunization against tumor necrosis factor α impairs host defense during pneumococcal pneumonia in mice. Am. J. Respir. Crit. Care Med. 155:603-608.
35. Van der Poll, T., C. V. Keogh, X. Guirao, W. A. Buurman, M. Kopf, and S. F. Lowry. 1997. Interleukin 6 gene deficient mice are more susceptible to pneumococcal pneumonia. J. Infect. Dis. 176:439-444.
36. Van der Poll, T., S. M. Coyle, M. Levi, P. M. Jansen, M. Dentener, K. Barbosa, W. A. Buurman, C. E. Hack, J. W. ten Cate, J. M. Agosti, and S. F. Lowry. 1997. Effects of recombinant dimeric TNF receptor on inflammatory responses to intravenous endotoxin in normal humans. Blood 89:3727-3736.